Salk Institute scientists discovered that bile acids in the liver can weaken immune cell function, making immunotherapy less effective against liver cancer. They pinpointed specific bile acids that ...

A new study examines the effects of cancer and its treatment on the aging process. Investigators found that expression of a gene associated with aging is higher in young patients with cancer after ...

The gastrointestinal tract is already known to researchers as a major storage site for micro- and nanoplastic particles (MNPs) in the human body. A research consortium has now investigated the effects ...

"Liver cancer cells are adept at surviving by using various escape routes," explained Professor Carmen Wong Chak-Lui from the Department of Pathology at the School of Clinical Medicine, HKUMed, who ...

Figure 1 BET inhibition is synthetic lethal to OXPHOS blockage in liver cancer. Left: GDH1-dependent glutamine metabolic remodeling upon BET inhibition. Right: “Synthetic lethality” targeting OXPHOS ...

A faulty cancer gene helps tumours evade immunity by stopping tumour cells releasing message-containing cargoes called exosomes. These findings, published today as a Reviewed Preprint in eLife, ...

David Pellman (left) is a professor at the Dana-Farber Cancer Institute and Harvard Medical School (both MA, USA), who also has affiliations with Howard Hughes Medical Institute (MD, USA) and the ...

A new study of liver cancer shows three ways to reduce the risk in the majority of cases. We learn more about what they are and what else the study found. The third leading cause of cancer death is ...

The treatment plan for liver cancer can vary depending on the stage, size, and location of the tumor. Common options include surgery, ablation, cryotherapy, immunotherapy, and targeted drug therapy.

Scientists at University of California San Diego School of Medicine have shed new light on the development of liver cancer, the sixth most frequently diagnosed cancer and fourth leading cause of ...